Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study.

Lundholm K, Gunnebo L, Körner U, Iresjö BM, Engström C, Hyltander A, Smedh U, Bosaeus I.

Cancer. 2010 Apr 15;116(8):2044-52. doi: 10.1002/cncr.24917.

4.

Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.

Lundholm K, Körner U, Gunnebo L, Sixt-Ammilon P, Fouladiun M, Daneryd P, Bosaeus I.

Clin Cancer Res. 2007 May 1;13(9):2699-706.

5.

Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.

Cannabis-In-Cachexia-Study-Group, Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko YD, Schnelle M, Reif M, Cerny T.

J Clin Oncol. 2006 Jul 20;24(21):3394-400.

PMID:
16849753
6.

Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study.

Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, Nakajima K, Fujiwara Y, Hosoda H, Kangawa K, Mori M, Doki Y.

Gastroenterology. 2010 Apr;138(4):1312-20. doi: 10.1053/j.gastro.2009.12.058. Epub 2010 Jan 11.

PMID:
20060830
7.

Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study.

Hotta M, Ohwada R, Akamizu T, Shibasaki T, Takano K, Kangawa K.

Endocr J. 2009;56(9):1119-28. Epub 2009 Sep 16.

8.

Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia.

Fouladiun M, Körner U, Gunnebo L, Sixt-Ammilon P, Bosaeus I, Lundholm K.

Clin Cancer Res. 2007 Nov 1;13(21):6379-85.

9.

Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.

Hansen TB, Gram J, Jensen PB, Kristiansen JH, Ekelund B, Christiansen JS, Pedersen FB.

Clin Nephrol. 2000 Feb;53(2):99-107.

PMID:
10711411
10.

Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia.

Lundholm K, Daneryd P, Körner U, Hyltander A, Bosaeus I.

Int J Oncol. 2004 Mar;24(3):505-12.

PMID:
14767534
11.

Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.

Garcia JM, Polvino WJ.

Growth Horm IGF Res. 2009 Jun;19(3):267-73. doi: 10.1016/j.ghir.2008.12.003. Epub 2009 Feb 3.

PMID:
19196529
12.

Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction.

Yamamoto K, Takiguchi S, Miyata H, Adachi S, Hiura Y, Yamasaki M, Nakajima K, Fujiwara Y, Mori M, Kangawa K, Doki Y.

Surgery. 2010 Jul;148(1):31-8. doi: 10.1016/j.surg.2009.11.026. Epub 2010 Jan 21.

PMID:
20096432
13.

Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.

Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17.

PMID:
11422104
14.
15.

Ghrelin restores 'lean-type' hunger and energy expenditure profiles in morbidly obese subjects but has no effect on postgastrectomy subjects.

Huda MS, Dovey T, Wong SP, English PJ, Halford J, McCulloch P, Cleator J, Martin B, Cashen J, Hayden K, Wilding JP, Pinkney J.

Int J Obes (Lond). 2009 Mar;33(3):317-25. doi: 10.1038/ijo.2008.270. Epub 2009 Feb 3.

PMID:
19188925
16.
17.

Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).

Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.

Growth Horm IGF Res. 2008 Aug;18(4):307-17. doi: 10.1016/j.ghir.2007.12.001. Epub 2008 Feb 20.

PMID:
18282776
19.

Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.

Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH, MacFarlane IA.

Clin Endocrinol (Oxf). 1997 Oct;47(4):439-46.

PMID:
9404442
20.

Supplemental Content

Support Center